Effervescent tablets are a special drug formulation characterized by the presence of effervescent disintegrants. Effervescent tablets use organic acids and basic carbonate (hydrogen) salts to react as effervescent disintegrants. When placed in water, an immediate effervescent reaction occurs, generating and releasing a large amount of carbon dioxide gas, which forms a boiling state, hence the name effervescent tablets.

Overview of Market Development

Driven by factors such as increasing health awareness, an aging population, and lifestyle changes, the global effervescent tablet market has shown a steady growth trend in recent years. According to our research data, the estimated global effervescent tablet market size in 2024 is $6229 million, an increase of 7.79% compared to 2023. In the next few years, with the further aging of the population and the continuous advancement of technology, this market is expected to continue expanding. It is expected that by 2029, the global effervescent tablet market size will reach $9095 million. The CAGR for 2024-2029 is estimated to be 7.86%.

Analysis of Market Competition Pattern

From the perspective of market competition, the concentration of the global effervescent tablet market is relatively high. According to our data, the total revenue of the top 3 companies in the effervescent tablet market in 2023 is $3381 billion, with a total revenue share of 50.31%. The top three companies were Bayer, GlaxoSmithKline, and Reckitt Benckiser LLC. In 2023, these three companies accounted for 22.61%, 17.36%, and 10.34% of the global market revenue in the effervescent tablet market, respectively.

Source: www.globalmarketmonitor.com

Segmented Market Analysis

From the perspective of product types, effervescent tablets can usually be divided into two categories: prescription effervescent tablets and over-the-counter (OTC) effervescent tablets, depending on whether they comply with medical advice. Among them, OTC effervescent tablets dominate the market. According to the data, the estimated market size of the global OTC effervescent tablets segment in 2024 is $4779 million, and the market share is expected to reach 76.72%.

	Market Revenue (Million USD)	Market Share
Segmented by Type
Prescription Effervescent Tablets	1450	23.28%
Over-The-Counter Effervescent Tablets	4779	76.72%